1H-13C NMR-based urine metabolic profiling in autism spectrum disorders.

Sylvie Mavel 1, * Lydie Nadal-Desbarats 2 Hélène Blasco 1 Frédérique Bonnet-Brilhault 3 Catherine Barthélémy 3 Frédéric Montigny 4 Pierre Sarda 5 Frédéric Laumonnier 1 Patrick Vourc'H 2 Christian R Andres 1 Patrick Emond 2
* Auteur correspondant
1 Equipe neurogénétique et neurométabolomique
Imagerie et cerveau
2 Equipe neurogénétique et neurométabolomique
Imagerie et cerveau, PPF "Analyses des Systèmes Biologiques"
3 Equipe Autisme
Imagerie et cerveau
4 PPF "Analyses des Systèmes Biologiques"
5 CHU de Montpellier
Abstract : Autism Spectrum Disorders (ASD) are a group of developmental disorders caused by environmental and genetic factors. Diagnosis is based on behavioral and developmental signs detected before 3 years of age with no reliable biological marker. The purpose of this study was to evaluate the potential use of a 2D NMR-based approach to express the global biochemical signature of autistic individuals compared to normal controls. This technique has greater spectral resolution than to 1D (1)H NMR spectroscopy, which is limited by overlapping signals. The urinary metabolic profiles of 30 autistic and 28 matched healthy children were obtained using a (1)H-(13)C NMR-based approach. The data acquired were processed by multivariate orthogonal partial least-squares discriminant analysis (OPLS-DA). Some discriminating metabolites were identified: β-alanine, glycine, taurine and succinate concentrations were significatively higher, and creatine and 3-methylhistidine concentrations were lower in autistic children than in controls. We also noted differences in several other metabolites that were unidentified but characterized by a cross peak correlation in (1)H-(13)C HSQC. Statistical models of (1)H and (1)H-(13)C analyses were compared and only 2D spectra allowed the characterization of statistically relevant changes [R(2)Y(cum)=0.78 and Q(2)(cum)=0.60] in the low abundance metabolites. This method has the potential to contribute to the diagnosis of neurodevelopment disorders but needs to be validated on larger cohorts and on other developmental disorders to define its specificity.
Keywords : HSQC NMR spectroscopy Autism spectrum disorders Urinary metabolites OPLS-DA Metabolomics
Type de document :
Article dans une revue
Talanta, Elsevier, 2013, 114, pp.95-102. 〈10.1016/j.talanta.2013.03.064〉
Liste complète des métadonnées

Littérature citée [24 références]  Voir  Masquer  Télécharger
http://www.hal.inserm.fr/inserm-00908985
Contributeur : Sylvie Mavel <>
Soumis le : lundi 25 novembre 2013 - 15:40:32
Dernière modification le : vendredi 29 juin 2018 - 13:28:01
Document(s) archivé(s) le : lundi 3 mars 2014 - 15:46:23

Fichier

TAL-revisedfinal.pdf
Fichiers produits par l'(les) auteur(s)

Identifiants

Collections

Citation

Sylvie Mavel, Lydie Nadal-Desbarats, Hélène Blasco, Frédérique Bonnet-Brilhault, Catherine Barthélémy, et al.. 1H-13C NMR-based urine metabolic profiling in autism spectrum disorders.. Talanta, Elsevier, 2013, 114, pp.95-102. 〈10.1016/j.talanta.2013.03.064〉. 〈inserm-00908985〉

Exporter

BibTeX TEI DC DCterms EndNote

Partager

Métriques

Consultations de la notice

452

Téléchargements de fichiers

304

Contact

support.ccsd.cnrs.fr
hal.support@ccsd.cnrs.fr
Logo CCSD